Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Antiemetics in Cancer Treatment

Publication Date: July 13, 2020

Last Updated: March 27, 2023

Treatment

Adult Patients

Note: For adult patients, the addition of a checkpoint inhibitor to chemotherapy does not change the guideline recommendation for an antiemetic regimen based on the emetogenicity of the agents administered. CPIs administered alone or in combination with another checkpoint inhibitor are minimally emetogenic and do not require the routine use of a prophylactic antiemetic.

Overview

Title

Antiemetics

Antiemetics in Cancer Treatment

Treatment

Adult Patients

Overview

Title

Authoring Organization